Zepp Health Corporation Q1 2026 Financial Results

Zepp Health Corporation reported its first quarter 2026 financial results, with revenues reaching US$51.5 million, a 33.8% year-over-year increase. The company's gross margin was 37.7%. As of March 31, 2026, cash and cash equivalents stood at US$103.2 million. The company launched new products including Amazfit Balance 3, Balance Ultra, Bip Max, Cheetah 2 Pro, and Cheetah 2 Ultra. Zepp Health also extended its HYROX partnership for three years and welcomed Rory Linkletter to its Amazfit Athletes team. For the second quarter of 2026, Zepp Health expects net revenues between US$63.0 million and US$68.0 million, representing a 6% to 14% year-over-year increase. The company is focusing on premiumization, product mix improvement, pricing power, and long-term profitability.